Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer

Triple-negative breast cancer (TNBC), representing ~15% of globally diagnosed breast cancer, is typically an incurable malignancy due to the lack of targetable surface targets for development of effective therapy. To address the unmet need for TNBC treatment, we recently determined that tissue facto...

Ausführliche Beschreibung